483 Chongqing Kangle Pharmaceutical Jan 2015

483 Chongqing Kangle Pharmaceutical Jan 2015

Nadeem Chaudhry FDA$119.00 - Available Now

FDA investigators audited the Chongqing Kangle Pharmaceutical - Chongqing, China facility and issued inspectional observations (via FDA 483) on 30 Jan 2015.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Jan 2015
  • Location: Chongqing, China
  • FEI: 3007088564
Add To Cart